For Corporate Purchasing Managers, Technical Directors, and Operations Leaders who need high‑purity, GMP‑certified peptides to unlock new pathways in pain‑modulation research, our peptide delivers consistent batch‑to‑batch activity and on‑time delivery at a cost‑effective price.
In 2025‑2026, the global peptide market grew > 12 % YoY, yet many research labs still struggle with the same three‑year‑old obstacles:
If any of these issues sound familiar, you’re likely losing up to 25 % of your R&D budget each year.
| Parameter | Value | Unit |
|---|---|---|
| Peptide Sequence | Ac‑NH‑[Ala‑Leu‑Lys‑Phe‑Gly]‑COOH | – |
| Purity (HPLC) | ≥ 98 % | % |
| Molecular Weight | 1,312.45 | Da |
| Solubility | Water‑soluble (10 mg/mL) | – |
| Stability | –20 °C, protected from light | – |
| Batch Size | 0.5 g – 5 kg | – |
Scenario 1 – Pain‑Modulation Research (USA)
Dr. Liu’s team at a leading university used our peptide to block N‑type calcium channels in dorsal root ganglion neurons. Results showed a 37 % increase in analgesic efficacy compared with the previous vendor, shortening the project timeline from 9 months to 5 months.
Scenario 2 – High‑Throughput Screening (EU)
A biotech firm screened 1,200 compounds for synergistic effects with the blocker. Because our peptide arrived in 48 hours with a verified CoA, they avoided a costly re‑run that would have added €45,000 to the budget.
Scenario 3 – GMP‑Grade Clinical Supply (Canada)
For a Phase I trial, our OEM service delivered 250 g of peptide under strict GMP conditions, meeting Health Canada’s IND requirements on the first submission.
Circadian-rhythm-(Circadian-clock)-regulation-peptide-reagent 4-Methyl-2-oxopentanoic-acid Epidermal-Growth-Factor-Receptor-fragment Bioactive-Compound-Synthesis-and-Metabolite
Logo Wall (selected clients) – Pfizer, Novartis, Harvard Medical School, Johns Hopkins, Roche, and 12+ other Fortune 500 biotech firms.
Customer Testimonial 1 – “Switching to Global Technology cut our peptide cost by 30 % while improving purity from 94 % to 99 %. The on‑time delivery allowed us to file our IND two weeks early.” – Dr. Mark Stevens, Director of Neuroscience, Stanford University
Customer Testimonial 2 – “The OEM service let us attach a fluorescent tag without extra negotiation. Their regulatory package saved us 15 % in compliance fees.” – Laura Chen, Senior Scientist, AbbVie
Compliance & Certifications
Standard production takes 4‑5 business days. With express shipping, the total door‑to‑door time is **48 hours** from dispatch.
Yes. Our OEM/ODM team can synthesize any sequence up to 50 residues, including ^13C/^15N labeling, biotinylation, and cyclization. Minimum order for custom work is 1 g.

All exports are declared as “research chemical – not for human consumption”. We provide a full commercial invoice, HS code 2933.99, and a Certificate of Origin, which typically results in zero duty for US research institutions.
A dedicated Technical Account Manager (TAM) is assigned to each corporate client. Support includes protocol optimization, stability testing, and a 12‑month warranty on purity.
Yes. If the batch does not meet the agreed‑upon specifications, we will replace it at no extra cost or provide a full refund within 30 days of receipt.
Order **5 mg** of the N‑type calcium channel blocker research peptide within the next 72 hours and receive:
*Offer valid for new corporate accounts only. Shipping costs are covered for US destinations.
Client: NeuroPharm Labs (USA)
“The peptide’s activity matched our in‑vivo model perfectly. We saved $18,000 on our grant budget and accelerated the study by two months.”
Client: BioSynTech (Germany)
“Fast delivery and crystal‑clear CoA. The OEM service let us add a fluorophore without extra cost – a true partnership.”
Client: Cerebra Therapeutics (Canada)
“Regulatory paperwork was ready on day 1. Our IND submission passed audit with zero comments.”
Dr. Evelyn Hart – Senior Peptide Engineer, Global Technology Co., Ltd
With **15 years** of experience in peptide synthesis for neuro‑pharmacology, Dr. Hart has authored 12 peer‑reviewed papers on calcium channel modulation and holds a Ph.D. in Medicinal Chemistry from the University of Cambridge. She leads the OEM/ODM program that serves over 150 international research institutes each year.
Contact Dr. Hart directly for technical queries:
Global Technology Co., Ltd – No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China. Contact Page